Vimarsana
Biggest News Aggregation in the World

Page 17 - Lancet Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lancet Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lancet Study Today - Breaking & Trending Today

Covid Patients At Increased Risk Of Psychiatric Conditions After 2 Years: Lancet Study - Vimarsana News

Covid Patients At Increased Risk Of Psychiatric Conditions After 2 Years: Lancet Study

Increased risk of neurological and psychiatric conditions such as dementia and seizures is still higher two years after COVID-19 compared to other respiratory infections, suggests an observational study published in Lancet Psychiatry journal.

Source: ndtv.com
Climate Change May Increase Mortality Rate Due to Excess Heat by Six Times: Lancet Study - Vimarsana News

Climate Change May Increase Mortality Rate Due to Excess Heat by Six Times: Lancet Study

"The risks of increasing temperature at night were frequently neglected," said study co-author Yuqiang Zhang, a climate scientist at the University of North Carolina. "However, in our study, we found that the occurrences of hot night excess (HNE) are projected to occur more rapidly than the daily mean temperature changes," Zhang said. 🍏 Climate Change May Increase Mortality Rate Due to Excess Heat by Six Times: Lancet Study.

Lancet study makes BIG breakthrough, says 1 in 8 SARS-CoV-2 patients develop long COVID symptoms | World News - Vimarsana News

Lancet study makes BIG breakthrough, says 1 in 8 SARS-CoV-2 patients develop long COVID symptoms | World News

The study looked at the symptoms most often associated with long COVID, including breathing problems, fatigue and loss of taste and smell, both before a COVID-19 diagnosis and in people who have not been diagnosed with the disease.

Source: india.com
Nasal Spray Lowers Covid Viral Load By 94% In 24 Hours: Lancet Study - Vimarsana News

Nasal Spray Lowers Covid Viral Load By 94% In 24 Hours: Lancet Study

A nasal spray administered in high-risk adult Covid patients in India reduced viral load by 94% within 24 hours and 99% in 48 hours, according to the results of phase 3 trial of the drug published in The Lancet Regional Health Southeast Asia journal.

Source: ndtv.com
Covid nasal spray reduces viral load by 94 percent in 24 hours 99 percent in 48 hours says Lancet Study Mumbai - Vimarsana News

Covid nasal spray reduces viral load by 94 percent in 24 hours 99 percent in 48 hours says Lancet Study Mumbai

Covid Nasal Spray: The trial evaluated a seven-day treatment of NONS plus standard of care versus placebo nasal spray and standard care in patients with symptomatic COVID-19.